Vendor, Meriden, CT, part of Sanofi
Protein Sciences Corp.
UEI NW32L3GCTBM8, CAGE 1EAP2
1 award and -$192,079 obligated between September 9, 2026 and September 9, 2026, 100% under full and open competition, against 3.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | -$192,079 |
Industries
NAICS on the awards, by dollars.
| Biological Product (except Diagnostic) ManufacturingNAICS 325414 | -$192,079 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSO100200900106CDefinitive Contract, September 9, 2026, Full and Open Competition, 3 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Advanced Development of Recombinant Influenza Vaccine.NAICS 325414, PSC AN13 | -$192,079 |
- Places of performance
- Connecticut
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 1 across 1 awards